Utah Medical Products Inc
UTMDNasdaqCIK 706698HealthcareFiscal year ends Dec 31
Reports and events: 227 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2215:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-26-001602 |
| 2026-08-3113:33 ET | 8-K | 7.01 Regulation FD disclosure | 0001096906-26-001326 |
| 2026-08-1213:57 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001096906-26-001210 |
| 2026-07-2315:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-26-001112 |
| 2026-05-1215:52 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001096906-26-000767 |
| 2026-05-0415:09 ET | 8-K | 5.07 Shareholder vote results | 0001096906-26-000685 |
| 2026-04-2315:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-26-000602 |
| 2026-04-0216:59 ET | DEF 14A | Proxy statementPeriod 2026-04-02 | 0001096906-26-000477 |
| 2026-03-2717:23 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001096906-26-000395 |
| 2026-01-2915:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-26-000161 |
| 2025-11-1414:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001096906-25-001839 |
| 2025-11-0413:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001096906-25-001733 |
| 2025-10-2315:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-25-001708 |
| 2025-08-1215:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001096906-25-001281 |
| 2025-07-2414:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-25-001180 |
| 2025-05-1515:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001096906-25-000816 |
| 2025-05-0516:57 ET | 8-K | 5.07 Shareholder vote results | 0001096906-25-000679 |
| 2025-04-2914:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-25-000625 |
| 2025-04-0417:15 ET | DEF 14A | Proxy statementPeriod 2025-04-04 | 0001096906-25-000427 |
| 2025-03-2617:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001096906-25-000308 |
| 2025-01-2815:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-25-000095 |
| 2024-11-1215:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001811884-24-000022 |
| 2024-11-0514:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001096906-24-002072 |
| 2024-10-2914:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-24-002035 |
| 2024-08-0916:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001811884-24-000018 |
| 2024-07-2514:44 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001096906-24-001590 |
| 2024-05-1011:18 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001811884-24-000015 |
| 2024-05-0615:05 ET | 8-K | 5.07 Shareholder vote results | 0001096906-24-001026 |
| 2024-04-2514:59 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001096906-24-000934 |
| 2024-04-1021:28 ET | DEF 14A | Proxy statementPeriod 2024-04-09 | 0001096906-24-000764 |
| 2024-03-2611:57 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001811884-24-000009 |
| 2024-01-3014:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-24-000127 |
| 2023-11-1310:49 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001811884-23-000021 |
| 2023-10-3112:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001096906-23-002066 |
| 2023-10-2615:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-23-002058 |
| 2023-08-1111:54 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001811884-23-000017 |
| 2023-07-2514:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-23-001449 |
| 2023-05-0815:47 ET | 8-K | 5.07 Shareholder vote results | 0001096906-23-000990 |
| 2023-05-0512:22 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001811884-23-000013 |
| 2023-04-2516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-23-000901 |
| 2023-04-0411:36 ET | DEF 14A | Proxy statementPeriod 2023-04-03 | 0001096906-23-000725 |
| 2023-03-2816:21 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001811884-23-000008 |
| 2023-03-2716:21 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001811884-23-000004 |
| 2023-01-3116:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-23-000240 |
| 2022-11-1011:19 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001811884-22-000015 |
| 2022-11-0114:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001096906-22-002609 |
| 2022-10-2514:48 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-22-002547 |
| 2022-08-1213:14 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001811884-22-000012 |
| 2022-07-2817:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001096906-22-001712 |
| 2022-05-1112:21 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001811884-22-000008 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:47 ET. Listed shows no prices and gives no investment advice.